Ameritas Investment Partners, Inc. Atreca, Inc. Transaction History

Ameritas Investment Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.56 - $3.25 $3,775 - $7,865	-2,420 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$12.67 - $23.19 $6,841 - $12,522	540 Added 28.72%	2,420 $34,000
Q2 2020 Aug 05, 2020	BUY	$12.52 - $23.45 $4,882 - $9,145	390 Added 26.17%	1,880 $40,000
Q1 2020 May 13, 2020	BUY	$11.4 - $27.28 $10,716 - $25,643	940 Added 170.91%	1,490 $25,000
Q3 2019 Nov 14, 2019	BUY	$10.42 - $22.04 $5,731 - $12,122	550 New	550 $7,000

1.04M

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.